MEDSIR

is over now

We would like to thank Brazil for making this possible and the dedicated team of MEDSIR who made this event a resounding success.

A heartfelt appreciation goes out to our esteemed mentors Javier, Josito, Toni, Mariana, Andreia, and Nadia, as well as to all the participants who traveled from across Brazil to join us.

We hope this experience has been both enlightening and enjoyable, fostering connections among like-minded individuals. Remember to think outside the box and that any idea could be a great idea. ⭐️

🇧🇷 Até logo, São Paulo! Obrigado for warmly hosting us during these days.

On , our thoughts are with the patients, healthcare professionals, and researchers.

At MEDSIR, we are dedicated to pushing the boundaries of breast cancer research. Founded in 2012 by scientific experts in the development of clinical research, Dr. Javier Cortés Castán, Dr. Antonio Llombart Cussac and Maria Campos, our mission is to create strategic synergies that accelerate the advancement of science. We conduct clinical trials like PHERGain, PARSIFAL, DEBBRAH, ATRACTIB, and MIRADOR, driven by our unwavering commitment to better outcomes for patients with different breast cancer types, including, HER2+, HR+/HER2-, metastatic, TNBC, and more.

*Prevention Matters: Breast cancer awareness extends to prevention. We encourage regular medical check-ups, self-examinations, and a healthy lifestyle. By detecting changes early, we can reduce the impact of this disease.

To learn more about MEDSIR's clinical trials and their contributions to the field of oncology research, please visit our website: https://www.medsir.org/